Literature DB >> 33289012

Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded.

Hisham Elkhider1, Faisal Ibrahim2, Sanjeeva Onteddu1, Krishna Nalleballe1.   

Abstract

Entities:  

Keywords:  COVID-19; Stroke

Year:  2020        PMID: 33289012      PMCID: PMC7710482          DOI: 10.1016/j.bbih.2020.100179

Source DB:  PubMed          Journal:  Brain Behav Immun Health        ISSN: 2666-3546


× No keyword cloud information.
Letter to the Editor We thank Landstrasse et al. for their interest in our work and for raising concerns regarding attributing Corona Virus Disease 2019 (COVID-19) related ischemic stroke to hypercoagulability. All the four patients described were on continuous cardiac monitoring during hospitalization and EKG on admission showed no atrial fibrillation or other arrhythmias. Patient 1 had elevated hypercoagulability and inflammatory markers except fibrinogen levels. He was monitored with an event monitor which did not show atrial fibrillation. Patient 2 was encephalopathic on presentation most likely due to severe COVID-19 and respiratory failure. Severe COVID-19 can cause encephalopathy (Umapathi et al., 2020; Shah et al., 2020). Magnetic resonance imaging (MRI) of the brain was not performed as mentioned in the article because the patient deteriorated rapidly and eventually passed away. The findings on CT scan of this patient are in the left MCA distribution which is more suggestive of ischemic stroke than encephalitis. The lesions on this CT scan don’t look like old lesions. It is important to mention that this scan was reviewed and reported as a stroke by a neuro-radiologist. Brain MRI of patient 3 is suggestive of embolic vs border zone infarctions. It was also mentioned in the article that hypotension is a possible cause of infarction in this patient. He didn’t have any signs of heart failure and as mentioned in the article, no low blood pressure was recorded during hospitalization. The cardiac mass was mentioned as a possible cause of stroke in patient 4 in the article in addition to COVID-19. The nature of the cardiac mass is unknown because the patient declined further work up prior to having the stroke and autopsy wasn’t performed. HBA1C was 9.8%, 6.0%, 6.1% and 14% for patients 1,2,3 and 4 respectively. Patient 3 is an ex-smoker and the other patients never smoked. All the reported patients had vessel imaging as mentioned in the article and table 1. None of them had vasculitis. As mentioned in the article, patient 1 and 2 had a CT angiogram of the head and neck, patient 3 and 4 had a magnetic resonance angiogram (MRA) of the head and neck. The article concluded that stroke can be a complication of severe COVID-19 because the 4 reported patients had severe infection with respiratory failure. We recognized that COVID-19 can be a cause ischemic stroke and we did not mention that this happens “ONLY” in severe infection. There are many articles connecting ischemic stroke to COVID-19 (Avula et al., 2020). We would not speculate that the prevalence of ischemic stroke has declined during the COVID-19 pandemic but we are of the opinion that the number of patients seeking medical care has decreased. As suggested by Siegler et al. the number of patients with ischemic stroke has declined in one tertiary center during the COVID-19 pandemic but that seems because a smaller number of patients seeking health care evaluation for mild symptoms (Siegler et al., 2020). Underutilization of healthcare resources is also observed during the COVID-19 pandemic (Onteddu et al., 2020). Given the nature of COVID-19 pandemic, this question can only be answered with further epidemiological research.

Funding

No funding was received.

Declaration of competing interest

The authors declare no conflicts of interest.
  5 in total

1.  Underutilization of health care for strokes during the COVID-19 outbreak.

Authors:  Sanjeeva R Onteddu; Krishna Nalleballe; Rohan Sharma; Aliza T Brown
Journal:  Int J Stroke       Date:  2020-06-18       Impact factor: 5.266

2.  Acute encephalopathy is associated with worse outcomes in COVID-19 patients.

Authors:  Vishank Arun Shah; Krishna Nalleballe; Mhd Ezzat Zaghlouleh; Sanjeeva Onteddu
Journal:  Brain Behav Immun Health       Date:  2020-09-01

3.  Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center.

Authors:  J E Siegler; M E Heslin; L Thau; A Smith; T G Jovin
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-14       Impact factor: 2.136

4.  COVID-19 presenting as stroke.

Authors:  Akshay Avula; Krishna Nalleballe; Naureen Narula; Steven Sapozhnikov; Vasuki Dandu; Sudhamshi Toom; Allison Glaser; Dany Elsayegh
Journal:  Brain Behav Immun       Date:  2020-04-28       Impact factor: 7.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.